Navigation Links
Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer
Date:3/31/2009

Inc., a private pharmaceutical company. In 2004, Narachi retired as an officer and Vice President and General Manager of Amgen's Anemia Business. Throughout his 20 years at Amgen, Narachi held various positions including: Product Development Team Leader for NEUPOGEN(R); Director of Clinical Operations in Thousand Oaks, Calif., and Cambridge, U.K.; Vice President of Development and Representative Director for Amgen Japan; Head of Corporate Strategic Planning; Chief Operations Officer of Amgen BioPharma; and Vice President, Licensing and Business Development. He is also a director of AMAG Pharmaceuticals, Inc.

Mr. Narachi received B.S. and M.A. degrees in Molecular Genetics from the University of California at Davis. He also received an M.B.A. from the Anderson Graduate School of Management at University of California, Los Angeles.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead combination product candidates targeted for obesity are Contrave, which is in Phase 3 clinical trials, and Empatic(TM), which is in the later stages of Phase 2 clinical development. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at http://www.orexigen.com.

Forward-Looking Statements

Orexigen cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "indicates," "will," "intends," "potential," "suggests," "assuming," "designed" and similar expressions are intended to identify forward-looking statements. These statements are
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Orexigen(R) Therapeutics Names Patrick Mahaffy to Board of Directors
2. Orexigen(R) Therapeutics to Speak at J.P. Morgan Healthcare Conference
3. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
4. Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City
5. Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
6. Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes
7. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
8. MRSA study suggests strategy shift needed to develop effective therapeutics
9. Cell Therapeutics, Inc. (CTI) President Craig Philips to Present at Invest Northwest
10. MPM Capital Leads Investment in Proteon Therapeutics
11. Cell Therapeutics Reschedules Special Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , ... August 27, 2015 , ... ... average annual cost to treat a patient with hemophilia is $175,000. Hemophilia is ... a cure and improving treatment. The RMHBDA exists to help raise funds for ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... According ... and the American Heart Association have released new guidelines to educate doctors and patients ... last update to these particular guidelines came in 2007, so the new version is ...
(Date:8/27/2015)... ... August 27, 2015 , ... Allegheny General Hospital (AGH), part ... medical centers in the United States to receive international recognition for an advanced, ... Extracorporeal Life Support Organization (ELSO) , an international consortium of healthcare institutions dedicated ...
(Date:8/27/2015)... ... , ... About 10 percent of mothers experienced chronic, persistent ... more than 1,800 people, displacing hundreds of thousands and causing widespread damage estimated ... While most people don’t develop persistent depression after a major disaster like that, ...
(Date:8/27/2015)... Hills, CA (PRWEB) , ... August 27, 2015 ... ... Wearables & IoT Summit , scheduled for October 27-29, 2015 in San Jose, ... technology, the summit will primarily focus on the void that exists where battery ...
Breaking Medicine News(10 mins):Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 2Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 3Health News:Avitus Group Encourages Business & Employee Community Involvement; Senior Level Staff Leads Way With Support of Rocky Mountain Hemophilia & Bleeding Disorders Association 4Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 2Health News:Article on New Diabetic Care Guidelines Shines Brightly on Weight Loss Surgery, notes Beverly Hills Physicians 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2
... of Women,s ... Ovarian Reserve, COLORADO ... announced it will be the first IVF center,in the region to ... an assessment of a woman,s egg supply by combining,multiple factors including ...
... claims companies knowingly misled consumers on the use of Zetia and ... ... Hagens Berman Sobol Shapiro filed,a proposed class-action lawsuit against Merck (NYSE: ... Vytorin alleging,Merck and Schering-Plough violated state consumer protection laws arising,from the sale ...
... Inc. (TSX: DDS,NASDAQ: DDSS) today announced that it ... iNova Pharmaceuticals (Australia) Pty Limited,for its once-daily tramadol ... of our once-daily tramadol product across,Europe and in ... as we,prepare for additional product launches in key ...
... 24 Weight Watchers,International, Inc. (NYSE: WTW ) ... year 2007 after the NYSE close on Thursday, February ... call on February 14th at,5:00 p.m. ET. During the ... Ann Sardini, Chief Financial Officer, will,discuss fourth quarter and ...
... with a camera could detect the earliest signs of cancer? ... in confined spaces. Such a device could find warning signs ... States. , A fundamentally new design has created a smaller ... to use than current technology. Its first use on a ...
... published today in the February issue of the ... of Biomaterials, Dalhousie University (Halifax, NS, Canada), and ... on Dentistry, denounces new Norwegian regulations governing the ... use of dental amalgam not only in Norway, ...
Cached Medicine News:Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 2Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 3Health News:Reproductive Medicine & Fertility Center is First in Southwest to Offer Pioneering Test of a Women's Biological Clock 4Health News:CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough 2Health News:CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough 3Health News:Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova 2Health News:Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova 3Health News:Weight Watchers Announces Fourth Quarter and Full Year 2007 Earnings Conference Call 2Health News:Camera in a pill offers cheaper, easier window on your insides 2Health News:Camera in a pill offers cheaper, easier window on your insides 3Health News:Materials expert denounces Norwegian ban on dental amalgam 2
(Date:8/27/2015)... , Aug. 27, 2015  BioElectronics Corporation (OTC Pink: BIEL), ... that three abstracts featuring the use of ActiPatch®, its ... 9 th Congress of the European Pain Federation ... September 2015. The Company will also be exhibiting ... Gianluca Bagnato , department clinical and experimental rheumatology ...
(Date:8/27/2015)... ATLANTA , August 27, 2015 ... Consortium convened in Boston on ... Consortium in an effort to more fully exploit the ... are applied to brain diseases. "As an ... has a responsibility to assume a leadership role - ...
(Date:8/27/2015)... FRANCISCO, Calif. , Aug. 27, 2015 /PRNewswire/ ... therapeutics for the treatment of cancer, today announced ... member of the company,s Board of Directors, has ... led immuno-oncology at Eli Lilly and AstraZeneca, and ... first FDA approved checkpoint inhibitor, at Bristol-Myers Squibb ...
Breaking Medicine Technology:BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 2Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: